Photo Credit: EyeEm

Physician’s Weekly has compiled a collection of noteworthy quotes from recent nephrology research, with a focus on age-related macular degeneration.

Recent research in ophthalmology has had a heavy focus on age-related macular degeneration (AMD), including risk factors that influence the condition, novel biomarkers, and associated costs. Below is a sampling of what your peers have had to say on these topics.

Inflammatory Index May Be New AMD Biomarker

“These findings suggest that [the systemic inflammatory response index] could be used as a biomarker for AMD risk assessment, which can greatly benefit patient care. Since it is derived from peripheral blood, its measurement is straightforward, cost-effective, and non-invasive.” — researchers in Frontiers in Nutrition

To read more, click here.

Lipoprotein Linked With AMD Risk

“These findings highlight an exciting application of the wealth of clinical and genetic data in the All of Us dataset to highlight novel associations with the retinal disease pathophysiology of AMD.” — Jimmy S. Chen, MD, and colleagues

To read more, click here.

Weight-Adjusted Waist Index as an AMD Biomarker

“The research underscores the potential of the [weight-adjusted weight index] as a reliable predictive biomarker for AMD.” — researchers in Frontiers in Medicine

To read more, click here.

Economic Burden of Late-Stage AMD

“Late-stage AMD imposes a substantial economic burden akin to other common non-life-threatening diseases, such as [Parkinson’s] disease and obesity. Reduced well-being and loss of productivity were relatively large contributors to the total economic burden.” — Nabin Paudel, PhD, and colleagues

To read more, click here.